Cornell Üniversitesi araştırmasına göre, Ozempic ve benzeri GLP-1 ilaçları kullanan hanelerde gıda harcamaları ortalama %5,3 azalıyor. En büyük düşüş yüksek kalorili ve işlenmiş gıdalarda görülürken, yoğurt ve meyve gibi ürünlere harcama artıyor.
Die Erpressergruppe FulcrumSec behauptet, Novo Nordisk habe eine Lösegeldzahlung von 25 Mio. USD verweigert, nachdem sie über ein Terabyte an Daten gestohlen hatten. Die Hacker drohen nun mit dem Verkauf der Daten, ziehen aber eine kostenlose Veröffentlichung vor, um andere Unternehmen abzuschrecken.
Grupo hacker FulcrumSec alega ter roubado mais de 700 mil arquivos da Novo Nordisk, incluindo dados de pacientes e funcionários, e ameaça vender as informações após não conseguir extorquir US$ 25 milhões da empresa.
使用“瘦瘦針”藥物“猛健樂”減重成功的網友，出現臉頰凹陷、法令紋加深等“猛健樂臉”困擾。專家指出，這是快速減重導致脂肪流失的必然結果，並提供運動、控制減重速度、精準營養及醫美修復等四種建議。
Peptídeos, promovidos como antienvelhecimento e para performance, carecem de comprovação científica e aprovação regulatória no Brasil. Especialistas alertam para riscos de uso sem orientação médica.
O reposicionamento de medicamentos, que consiste em encontrar novos usos para fármacos já existentes, tem se mostrado uma estratégia eficaz e econômica para salvar vidas, especialmente em crises de saúde como a da COVID-19. Medicamentos como a dexametasona e o baricitinibe foram reaproveitados para tratar a inflamação em pacientes com coronavírus, salvando milhares de vidas. A Comissão Europeia planeja expandir essa abordagem para a busca de tratamentos contra o câncer. Exemplos históricos incluem o raloxifeno para prevenção de câncer de mama, a talidomida para mieloma múltiplo e o Viagra (sildenafil) para disfunção erétil, originalmente desenvolvido para doenças cardiovasculares. A tendência de reaproveitamento de medicamentos levanta questões sobre seus verdadeiros prós e contras, cujas respostas podem levar anos para serem totalmente compreendidas.
Des utilisateurs d'Ozempic et d'autres médicaments amaigrissants rapportent une nouvelle obsession pour les parfums gourmands, certains allant jusqu'à les utiliser comme substituts de repas. D'autres se plaignent d'effets secondaires olfactifs moins agréables.
The article explores drug repurposing, highlighting GLP-1 agonists like Ozempic and Wegovy, initially for diabetes, now used for weight loss, cardiovascular health, and more. It also discusses COVID-19 treatments like dexamethasone and baricitinib, and historical examples like raloxifene, thalidomide, BCG vaccine, and Viagra, emphasizing both the benefits and potential risks of using drugs for unapproved conditions.
New research suggests GLP-1 agonists like Ozempic could cut breast cancer risk by 30%. A retrospective study found a significant reduction in incidence among women using these drugs, potentially due to weight loss and anti-inflammatory effects.
Dezessete pessoas foram presas em Salvador em uma operação contra um grupo suspeito de roubo a farmácias, tráfico de drogas e armas, e lavagem de dinheiro. A ação também cumpre mandados no Rio de Janeiro e São Paulo, com bloqueio de bens de R$ 12,5 milhões.
A new analysis shows semaglutide (Ozempic/Wegovy) slows kidney disease progression in type 2 diabetes patients, improving kidney function and survival rates, even with a history of cardiovascular events. The drug mimics GLP-1 hormones and is also popular for weight loss.
Medicamento para obesidade, semaglutida, chega ao Brasil com preço acessível. Versão nacional da EMS custará R$ 287 por mês na fase inicial, bem abaixo dos R$ 1 mil mensais anteriores.
Biomagistral, a Brazilian compounding pharmacy network, is expanding internationally with a model integrating human and veterinary services. The company plans to open branches in Argentina, Spain, and Colombia, leveraging trends in personalized medicine and pet care.
Retatrutide, a new obesity drug from Eli Lilly, has shown a 30% weight loss in trials, surpassing previous drugs like Ozempic. It mimics GLP-1 and other hormones, offering benefits beyond weight loss, including anti-inflammatory effects.
Retatrutide, a new obesity drug, has shown a 30% weight loss in trials, surpassing previous drugs. Experts highlight its broader benefits beyond weight loss, including reduced inflammation and improved cardiovascular and kidney function, attributing these to its multi-organ receptor action.
A new study suggests GLP-1 drugs, known for weight loss and diabetes treatment, may slow the progression of certain obesity-related cancers. Comparing GLP-1 users to those on DPP-4 inhibitors, researchers found reduced cancer spread in lung, breast, colorectal, and liver cancers.
India has become one of the first countries to introduce cheaper, generic brands of weight loss drugs like Ozempic and Wegovy, but health professionals warn a lack of regulation and oversight is causing problems.
India has become one of the first countries to introduce cheaper, generic brands of weight loss drugs like Ozempic and Wegovy, but health professionals warn a lack of regulation and oversight is causing problems.
New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.
Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.
Semaglutid içeren GLP-1 ilaçları (Ozempic, Wegovy, Mounjaro), Tip 2 diyabet ve obezite tedavisinde kullanımı artan ilaçlar. ABD'de obezite oranlarının yüksek olduğu eyaletlerde GLP-1 kullanımı da yoğunlaşıyor. En yüksek kullanım yüzde 24 ile West Virginia'da, en düşük yüzde 5 ile Hawaii'de. İlaçların aylık maliyeti 25-1.112 dolar arasında değişirken, Hindistan'da jenerik versiyonları yüzde 60'a varan indirimle satışa sunuluyor. DSÖ, uzun dönem verilerin sınırlı olduğunu vurguluyor.
Novo Nordisk is relaunching a diabetes tablet under the Ozempic brand in the United States, leveraging the strong brand recognition of its popular injectable drug. The new Ozempic pills will be available in specific doses for adults starting Monday, as the company seeks to regain market share from competitor Eli Lilly.
Rebel Wilson has lost over 80 pounds through gradual lifestyle changes including daily walking, strength training and mindful eating, while clarifying that Ozempic played only a supporting role and was not her primary method. The actor, who declared 2020 her 'year of health,' now emphasizes sustainability over intensity and has shifted focus from weight loss to overall wellbeing, recently stating she may never have a 'bikini body' but is grateful. A 2026 defamation case involving her film The Deb has brought renewed attention to her public profile.
İngiliz Estetik Plastik Cerrahlar Derneği (BAAPS), Ozempic ve benzeri zayıflama ilaçlarının neden olduğu kas dokusu kaybı ve 'çökmüş yüz' sendromu nedeniyle estetik cerrahi başvurularında keskin bir artış olduğunu açıkladı. Kaş kaldırma operasyonları yüzde 25, yüz ve boyun germe yüzde 11, göz kapağı estetiği yüzde 8 arttı. Uzmanlar, ilaçların vaat ettiği hızlı zayıflamanın beklenenden fazla kas kaybına yol açtığını ve bunun geri dönüşümsüz estetik deformasyonlara neden olduğunu belirtiyor.
